• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在由甲状腺球蛋白启动子驱动表达人活化Ras基因的转基因小鼠中的甲状腺病变

Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter.

作者信息

Rochefort P, Caillou B, Michiels F M, Ledent C, Talbot M, Schlumberger M, Lavelle F, Monier R, Feunteun J

机构信息

Laboratoire de Génétique Oncologique, URA 1967 CNRS, Institut Gustave Roussy, Villejuif, France.

出版信息

Oncogene. 1996 Jan 4;12(1):111-8.

PMID:8552381
Abstract

Four transgenic mice carrying the human activated c-Ha-Ras gene, the expression of which was driven into the thyroid gland by a bovine thyroglobulin promoter, have been produced. The M1 and M2 mice developed papillary thyroid carcinomas and the M2 mouse also developed a lung carcinoma, however none of them transmitted the transgene. Both the M3 and the M4 mice gave rise to transgenic lines. M3 progeny mice develop a goitre with morphological aspects of hyperplasia as well as a thymus hyperplasia. M4 developed a papillary thyroid carcinoma and a lung carcinoma. Lung tumors but not thyroid tumors were observed in M4 adult transgenic progeny. In this M4 line, thyroid dysgenesis leading to growth retardation and premature death was observed upon serial backcross that enhanced the DBA/2J genetic background. The development of thyroid tumors in M1, M2, M4 transgenic mice demonstrates the oncogenic potential of activated Ras gene in the thyroid gland. The M4 line raises interesting questions relative to the interference between the Ras-mediated signal transduction pathway and thyroid morphogenesis.

摘要

已培育出四只携带人类活化型c-Ha-Ras基因的转基因小鼠,该基因的表达由牛甲状腺球蛋白启动子驱动进入甲状腺。M1和M2小鼠发生了甲状腺乳头状癌,M2小鼠还发生了肺癌,然而它们均未传递转基因。M3和M4小鼠都产生了转基因品系。M3子代小鼠出现了具有增生形态学特征的甲状腺肿以及胸腺增生。M4发生了甲状腺乳头状癌和肺癌。在M4成年转基因子代中观察到了肺部肿瘤,但未观察到甲状腺肿瘤。在这个M4品系中,在连续回交以增强DBA/2J遗传背景时,观察到甲状腺发育不全导致生长迟缓和过早死亡。M1、M2、M4转基因小鼠中甲状腺肿瘤的发生证明了活化型Ras基因在甲状腺中的致癌潜力。M4品系提出了关于Ras介导的信号转导途径与甲状腺形态发生之间干扰的有趣问题。

相似文献

1
Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter.在由甲状腺球蛋白启动子驱动表达人活化Ras基因的转基因小鼠中的甲状腺病变
Oncogene. 1996 Jan 4;12(1):111-8.
2
Expression of v-Ha-ras driven by the calcitonin/calcitonin gene-related peptide promoter: a novel transgenic murine model for medullary thyroid carcinoma.由降钙素/降钙素基因相关肽启动子驱动的v-Ha-ras表达:一种新型甲状腺髓样癌转基因小鼠模型。
Oncogene. 1998 Jan 15;16(2):167-77. doi: 10.1038/sj.onc.1201478.
3
Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoter.
Cancer Res. 1993 Nov 15;53(22):5523-7.
4
Transgenic mice carrying the human KRAS oncogene under the control of a thyroglobulin promoter: KRAS expression in thyroids analyzed by in situ hybridization.在甲状腺球蛋白启动子控制下携带人类KRAS癌基因的转基因小鼠:通过原位杂交分析甲状腺中的KRAS表达。
Oncol Res. 1996;8(2):85-93.
5
The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.TRK-T1融合蛋白诱导甲状腺上皮细胞发生肿瘤转化。
Oncogene. 2000 Nov 23;19(50):5729-35. doi: 10.1038/sj.onc.1203922.
6
Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene.在表达A2a腺苷受体基因和人乳头瘤病毒16型E7癌基因的转基因小鼠中转移性分化型甲状腺癌的早期发生。
Oncogene. 1996 Oct 3;13(7):1471-82.
7
Targeted oncogenesis in the thyroid of transgenic mice.
Horm Res. 1997;47(4-6):137-9. doi: 10.1159/000185456.
8
Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells.由甲状腺球蛋白启动子驱动的人类N-ras、TRK-T1和RET/PTC3癌基因对分化标志物的表达和甲状腺上皮细胞的增殖有不同影响。
Oncol Res. 1999;11(9):421-7.
9
Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgene.
Oncogene. 1995 May 4;10(9):1789-97.
10
A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.串联重复的甲状腺球蛋白核心启动子有潜力增强甲状腺癌组织特异性基因治疗的疗效。
Cancer Gene Ther. 2002 Oct;9(10):864-74. doi: 10.1038/sj.cgt.7700511.

引用本文的文献

1
Development of animal models to study aggressive thyroid cancers.用于研究侵袭性甲状腺癌的动物模型的开发。
Eur Thyroid J. 2025 Feb 10;14(1). doi: 10.1530/ETJ-24-0361. Print 2025 Feb 1.
2
Mouse Models to Examine Differentiated Thyroid Cancer Pathogenesis: Recent Updates.探讨分化型甲状腺癌发病机制的小鼠模型:最新进展。
Int J Mol Sci. 2023 Jul 6;24(13):11138. doi: 10.3390/ijms241311138.
3
Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes.在 RAS 驱动的分化型甲状腺癌中存在额外的致癌改变与更差的临床病理结局相关。
Clin Cancer Res. 2023 Jul 14;29(14):2678-2685. doi: 10.1158/1078-0432.CCR-23-0278.
4
Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer.RAS突变在甲状腺良性结节和非髓样甲状腺癌中的意义
Cancers (Basel). 2021 Jul 27;13(15):3785. doi: 10.3390/cancers13153785.
5
Molecular profiling of thyroid nodule fine-needle aspiration cytology.甲状腺结节细针抽吸细胞学的分子分析。
Nat Rev Endocrinol. 2017 Jul;13(7):415-424. doi: 10.1038/nrendo.2017.24. Epub 2017 Mar 31.
6
KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1.KRAS(G12D)介导的甲状腺滤泡细胞致癌转化需要长期促甲状腺激素刺激,并受SPRY1调控。
Lab Invest. 2015 Nov;95(11):1269-77. doi: 10.1038/labinvest.2015.90. Epub 2015 Jul 6.
7
Mouse models of thyroid cancer: A 2015 update.甲状腺癌小鼠模型:2015年更新
Mol Cell Endocrinol. 2016 Feb 5;421:18-27. doi: 10.1016/j.mce.2015.06.029. Epub 2015 Jun 27.
8
NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma.NRAS基因第61位密码子突变与滤泡状甲状腺癌患者的远处转移相关。
Thyroid. 2014 Aug;24(8):1275-81. doi: 10.1089/thy.2014.0053. Epub 2014 Jun 11.
9
Genetics and epigenetics of sporadic thyroid cancer.散发性甲状腺癌的遗传学和表观遗传学。
Mol Cell Endocrinol. 2014 Apr 5;386(1-2):55-66. doi: 10.1016/j.mce.2013.07.030. Epub 2013 Aug 8.
10
RAS mutations in thyroid cancer.甲状腺癌中的 RAS 突变。
Oncologist. 2013;18(8):926-32. doi: 10.1634/theoncologist.2013-0072. Epub 2013 Jul 19.